ClinicalTrials.Veeva

Menu

Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage

U

University Hospital Schleswig-Holstein (UKSH)

Status

Unknown

Conditions

Keloid
Cicatrix, Hypertrophic

Treatments

Drug: Silicone gel (Dermatix®)

Study type

Interventional

Funder types

Other

Identifiers

NCT00565552
Dermatix01

Details and patient eligibility

About

So far the evaluation of scar treatment was based on subjective criteria. The patient groups were divided into treated versus non-treated.

In this study we use patients undergoing ear reconstruction with autologous rib cartilage. The thoracic scar of harvesting the rib cartilage is routinely reopened after 3 month during second stage of reconstruction. Therefore we have a ideal model of clinical, physiological and histological scar evaluation in a homologous patient group.

All patients randomly treat one half of the scar with a silicone gel (Dermatix). The other half is untreated as an internal control.

Enrollment

20 estimated patients

Sex

All

Ages

9+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with high grade microtia requiring a reconstruction with autologous rib cartilage

Exclusion criteria

  • diabetes mellitus
  • vascular disease
  • known allergic reaction to silicone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

1
Active Comparator group
Description:
Each patient uses the silicone gel on one half of the scar, leaving the other one blank as an internal control.
Treatment:
Drug: Silicone gel (Dermatix®)

Trial contacts and locations

1

Loading...

Central trial contact

Henning Frenzel, MD; Stefan Nitsch, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems